About the Event
The world is now a global stage where collaborations and synergistic partnerships have seen multinational companies make tremendous progress in building global firms with global reach. On the Tech side, Facebook, Google, Amazon are typical definitions of firms with global reach. Pharmaceuticals like Pfizer, GSK in addition to consulting firms like McKinsey, BCG, Bain and Company, the big fours among other corporations are part of the networks of firms with global reach. Their services cut across countries and continents and their impact of higher magnitude.
The question in the mind of entrepreneurs and founder today is - “How do we go global with this nascent idea from our local geography?” “How do we build the right team for global competitiveness?”
In this series of WES panel, we are inviting experts in intellectual property right, developmental science, communication and team-building specialists to help us dissect the power of team building, the legal (intellectual property) angle for global businesses, developing your idea for global competitiveness, how to prepare your idea for the global stage and tell the most exciting story with impact. We hope to x-ray how you can build those unicorns from your local idea. Please join us again in this interesting conversation.
The panel will be moderated by David Izuogu, the Wolfson Entrepreneurs Society President.
About the Panellists
Associate Patent Attorney at J A Kemp
Joe started his career at the London office of J A Kemp before joining our Cambridge based team in 2018 to help grow our local client base in the area.
Joe advises on matters from general protection strategy, to freedom-to-operate, to infringement of rights. He particularly enjoys working with young and growing companies to develop their patent portfolios and relishes working closely with inventors to draft new patent applications. Joe’s clients include individual inventors, university spin-outs, and technology transfer organisations, as well as large multi-nationals, and he understands how to cater for the specific needs of each. He has particular experience advising clients for whom out-licencing of intellectual property rights is paramount to their business model, and who require a robust approach to enforcing those rights against third parties, when encroached.
Joe is recognised for his ability to quickly grasp new concepts, identify potential inventions and translate those clearly into registered intellectual property rights. With a technical background in physics, he is able to cover a wide range of technical areas including software, image processing, electronics, optics, semiconductors, mechanical devices, sports apparel, medical devices, engineering and aerospace. Joe also frequently works on cases with an element of cross-over with the life sciences.
Joe joined J A Kemp in 2011 and became an associate in 2016.
Artistic Director at Menagerie
Paul works in creative engagement in three key sectors; as a theatre director and producer, as a teacher in entrepreneurship and as a consultant in arts and business training and project management.
Paul is the Artistic Director of Menagerie, a Cambridge-based theatre company which creates and tours New Writing Theatre productions worldwide. Formerly Artistic Director of The Frankfurt Playhouse and Center Stage New York, Paul regularly freelance directs and teaches theatre in the UK, Europe and the US. Over the past 25 years he has directed and produced over 80 professional productions in 10 different countries. He has also been the Artistic Director of The Hotbed Festival of New Writing at The Junction in Cambridge since 2002, and Chairman of the Jury for the Brno International Theatre Festival, Czech Republic. He regularly teaches performance skills as international ‘expert’ at the Russian Theatre Leaders School, Meyerhold Theatre, Moscow.
In Executive Education his key areas of interest and research are working alongside artists exploring creativity in the workplace, enterprise thinking, collaborative working, communication impact and transformational leadership. He has most recently worked with a wide variety of retained clients focusing on two key areas: cultural shift with The Dubai Stock Exchange (DIFC), Liverpool Football Club and Sberbank (Russia), and communication impact programmes for management and staff with Fairtrade, United States Armed Forces, Novartis and Zurich Insurance. His work as a master coach in EPIC Presentation Skills has been utilised by Chief Executives and Board Members of Novartis, Procter & Gamble, Fairtrade and Philip Morris.
Paul also teaches Enterprise and Creativity as an Associate at CEDAR in Cambridge, on the MBA and Executive Education courses at Moscow School of Management and Stockholm School of Economics.
As an International Arts consultant, Paul works with a wide variety of organisations including Trans Europe Halles (Arts Planning), Wroclaw ECOC (European Capital of Culture; Audience Development) and Creative Kosice (Artistic Interventions in the workplace). He is also currently working with CEDAR in Cambridge as a consultant on incubating new business in South Africa and Uruguay.
Chief Development Officer at Confo Therapeutics
Paolo Vicini joined Confo Therapeutics as CDO in 2020.
Over the last 20 years, Dr. Vicini has worked as an expert in pharmacology and drug development in the international biopharmaceutical industry and academia. He held positions including Vice President Development Sciences at Kymab Ltd. in Cambridge U.K and Senior Director of Translational Sciences, Clinical Pharmacology, Pharmacometrics and Drug Metabolism and Pharmacokinetics at MedImmune’s Cambridge U.K. site. Dr. Vicini was a Research Fellow, Biotherapeutics and Translational Research, with Pharmacokinetics, Dynamics and Metabolism at Pfizer Worldwide Research and Development in California for seven years. Prior to that, he was a faculty member with the Department of Bioengineering, University of Washington, Seattle, Washington (US).
Dr. Vicini has received multiple honours, is a Fellow of the American Association of Pharmaceutical Scientists and a member of several professional organizations. He has over 140 publications in diverse areas including oncology-targeted agents, diabetes, immunotherapy and immunogenicity of biotherapeutics, dose optimization as well as pharmacometrics and systems pharmacology.
Dr. Vicini obtained his PhD in Bioengineering from the Polytechnic of Milan and the University of Padova (Italy) and finished his MBA in 2014 from the University of Southern California in Los Angeles (US).
Date: Monday 2 November 2020
Time: 18:00 - 19:30 (GMT)
Location: Live across the listed platforms (see hyperlinks below)
Twitter - @wolfson_wes
Facebook - Wolfson Entrepreneurs Society Facebook page
Youtube - Wolfson Entrepreneurs Society YouTube channel
